ALLK - Allakos Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Redwood City,
United States
Type: Equity
ALLK price evolution
ALLK
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.5 | $43.06 | $66.44 | |
| Short term investments | $96.63 | $96.19 | $104.35 | |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $97.15 | $127.93 | $147.63 | $179.89 |
| Long term investments | ||||
| Property, plant & equipment | $25.61 | $26.82 | $27.94 | $57.51 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $28.53 | $29.68 | $63.72 | |
| Total investments | $96.63 | $96.19 | $104.35 | |
| Total assets | $124.43 | $156.46 | $177.31 | $243.61 |
| Current liabilities | ||||
| Accounts payable | $3.96 | $16.12 | $15.75 | $1.76 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $15.98 | $35.88 | $35.92 | $36.58 |
| Long term debt | $36.58 | $37.41 | $38.22 | |
| Total noncurrent liabilities | $36.58 | $37.41 | $38.22 | |
| Total debt | $36.58 | $37.41 | $38.22 | |
| Total liabilities | $51.69 | $72.46 | $73.33 | $74.79 |
| Shareholders' equity | ||||
| Retained earnings | -$1234.67 | -$1216.3 | -$1189.62 | -$1118.48 |
| Other shareholder equity | $0.33 | $0.01 | $0.02 | $0.05 |
| Total shareholder equity | $84 | $103.98 | $168.82 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $66.44 | $87.22 | $152.82 | $207.18 |
| Short term investments | $104.35 | $192.57 | $271.42 | $451.82 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $179.89 | $308.84 | $451.58 | $669.27 |
| Long term investments | ||||
| Property, plant & equipment | $57.51 | $69.37 | $74.81 | $48.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $63.72 | $77.58 | $83.24 | $50.35 |
| Total investments | $104.35 | $192.57 | $271.42 | $451.82 |
| Total assets | $243.61 | $386.42 | $534.82 | $719.62 |
| Current liabilities | ||||
| Accounts payable | $1.76 | $4.83 | $13.69 | $13.96 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $36.58 | $30.04 | $40.25 | $22.45 |
| Long term debt | $38.22 | $45.95 | $49.1 | $42.77 |
| Total noncurrent liabilities | $38.22 | $45.95 | $49.1 | $42.77 |
| Total debt | $38.22 | $45.95 | $49.1 | $42.77 |
| Total liabilities | $74.79 | $75.99 | $89.35 | $65.22 |
| Shareholders' equity | ||||
| Retained earnings | -$1118.48 | -$932.78 | -$612.82 | -$342.96 |
| Other shareholder equity | $0.05 | -$0.28 | -$0.15 | $0.01 |
| Total shareholder equity | $168.82 | $310.43 | $445.48 | $654.39 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $19.42 | $34.82 | $53.8 | |
| Selling, general & administrative | $9.21 | $10.9 | $11.18 | |
| Total operating expenses | $28.63 | $73.07 | $64.98 | |
| Operating income | -$28.63 | -$73.07 | -$64.98 | |
| Income from continuing operations | ||||
| EBIT | -$28.64 | -$73.14 | -$64.93 | |
| Income tax expense | ||||
| Interest expense | -$1.96 | -$2 | -$2.38 | |
| Net income | ||||
| Net income | -$26.68 | -$71.15 | -$62.55 | |
| Income (for common shares) | -$26.68 | -$71.15 | -$62.55 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $150.91 | $265.08 | $196.33 | $105.53 |
| Selling, general & administrative | $45.15 | $57.35 | $75.15 | $51.52 |
| Total operating expenses | $196.06 | $322.43 | $271.48 | $157.06 |
| Operating income | -$196.06 | -$322.43 | -$271.48 | -$157.06 |
| Income from continuing operations | ||||
| EBIT | -$196.05 | -$323.63 | -$270.24 | -$157.79 |
| Income tax expense | ||||
| Interest expense | -$10.35 | -$3.67 | -$0.38 | -$4.31 |
| Net income | ||||
| Net income | -$185.7 | -$319.95 | -$269.86 | -$153.48 |
| Income (for common shares) | -$185.7 | -$319.95 | -$269.86 | -$153.48 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$26.68 | -$71.15 | -$62.55 | |
| Operating activities | ||||
| Depreciation | $1.22 | $2.22 | $1.93 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.7 | $6.21 | $10.2 | |
| Total cash flows from operations | -$16.92 | -$32.54 | -$24.27 | |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$0 | $0.03 | |
| Investments | $0.4 | $9.03 | $20.16 | |
| Total cash flows from investing | $24.96 | $0.36 | $9.03 | $20.19 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.13 | |||
| Net borrowings | ||||
| Total cash flows from financing | $0.18 | $0.13 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$55.99 | -$16.56 | -$23.38 | -$4.08 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$185.7 | -$319.95 | -$269.86 | -$153.48 |
| Operating activities | ||||
| Depreciation | $7.63 | $9.97 | $4.88 | $2.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $41.22 | $43.16 | $50.84 | $33.45 |
| Total cash flows from operations | -$116.48 | -$279.97 | -$207.85 | -$113.92 |
| Investing activities | ||||
| Capital expenditures | -$0.59 | -$7.16 | -$33.22 | -$0.63 |
| Investments | $93.77 | $78.84 | $176.46 | $4.53 |
| Total cash flows from investing | $93.17 | $71.68 | $143.24 | $3.9 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.53 | $141.88 | $10.26 | $278.84 |
| Net borrowings | ||||
| Total cash flows from financing | $2.53 | $141.88 | $10.26 | $278.84 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$20.78 | -$66.41 | -$54.35 | $168.81 |
News
Fundamentals
| Market cap | $29.40M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 89.34M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.44 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 6.08 |
| Quick ratio | N/A |